A spontaneously arising pancreatic tumor does not promote the differentiation of naive CD8+ T lymphocytes into effector CTL

被引:66
作者
Lyman, MA [1 ]
Aung, S [1 ]
Biggs, JA [1 ]
Sherman, LA [1 ]
机构
[1] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
关键词
D O I
10.4049/jimmunol.172.11.6558
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
In this report, we address whether a growing tumor provides sufficient inflammatory signals to promote activation, clonal expansion, and acquisition of effector functions by naive tumor-specific CD8(+) T lymphocytes. CD8(+) T lymphocytes obtained from hemagglutinin (HA)-specific clone 4 TCR-transgenic mice were injected into recipient mice that spontaneously develop pancreatic tumors expressing HA as a tumor-associated Ag (RIP-Tag2-HA mice). When 3 X 10(6) clone 4 CD8(+) T cells were transferred into tumor-bearing mice, the cells became activated in the pancreatic lymph nodes where they proliferated and acquired effector functions such as cytolytic activity and IFN-gamma production. Surprisingly, reducing the number of adoptively transferred CD8(+) T cells led to a parallel reduction in the proportion of the activated cells that exhibited effector functions, suggesting that CTL differentiation was induced by the large numbers of activated CD8(+) T cells and not the tumor environment. Provision of tumor-specific CD4(+) helper cells provided the signals required to promote both the development of CTL effector functions and increased clonal expansion, resulting in tumor eradication. Considering that only small numbers of tumor-specific CD8(+) T cells would be present in a conventional T cell repertoire, these data suggest that tumor growth alone may not provide the inflammatory signals necessary to support the development of CD8(+) T cell effector functions.
引用
收藏
页码:6558 / 6567
页数:10
相关论文
共 51 条
[1]
NONTOLERANCE AND AUTOANTIBODIES TO A TRANSGENIC SELF ANTIGEN EXPRESSED IN PANCREATIC BETA-CELLS [J].
ADAMS, TE ;
ALPERT, S ;
HANAHAN, D .
NATURE, 1987, 325 (6101) :223-228
[2]
Compromised influenza virus-specific CD8+-T-Cell memory in CD4+-T-cell-deficient mice [J].
Belz, GT ;
Wodarz, D ;
Diaz, G ;
Nowak, MA ;
Doherty, PC .
JOURNAL OF VIROLOGY, 2002, 76 (23) :12388-12393
[3]
Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[4]
Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance [J].
Bonifaz, L ;
Bonnyay, D ;
Mahnke, K ;
Rivera, M ;
Nussenzweig, MC ;
Steinman, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (12) :1627-1638
[5]
A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory [J].
Bourgeois, C ;
Rocha, B ;
Tanchot, C .
SCIENCE, 2002, 297 (5589) :2060-2063
[6]
Signal 3 determines tolerance versus full activation of naive CD8 T cells: Dissociating proliferation and development of effector function [J].
Curtsinger, JM ;
Lins, DC ;
Mescher, MF .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1141-1151
[7]
Cancer immunoediting: from immunosurveillance to tumor escape [J].
Dunn, GP ;
Bruce, AT ;
Ikeda, H ;
Old, LJ ;
Schreiber, RD .
NATURE IMMUNOLOGY, 2002, 3 (11) :991-998
[9]
Eradication of established tumors by CD8+ T cell adoptive immunotherapy [J].
Hanson, HL ;
Donermeyer, DL ;
Ikeda, H ;
White, JM ;
Shankaran, V ;
Old, LJ ;
Shiku, H ;
Schreiber, RD ;
Allen, PM .
IMMUNITY, 2000, 13 (02) :265-276
[10]
Cross-tolerance: A pathway for inducing tolerance to peripheral tissue antigens [J].
Heath, WR ;
Kurts, C ;
Miller, JFAP ;
Carbone, FR .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1549-1553